178 related articles for article (PubMed ID: 11323859)
21. Emergent antibiotic resistance: health risks and economic impact.
Cassell GH
FEMS Immunol Med Microbiol; 1997 Aug; 18(4):271-4. PubMed ID: 9348162
[No Abstract] [Full Text] [Related]
22. ESCAIDE 2015: an operational scientific conference on infectious diseases for professionals from Europe and beyond.
Sabbatucci M; Jasir A
Euro Surveill; 2016; 21(11):30166. PubMed ID: 27020459
[No Abstract] [Full Text] [Related]
23. Antibiotic resistance. An impending crisis.
Mah MW; Memish ZA
Saudi Med J; 2000 Dec; 21(12):1125-9. PubMed ID: 11360084
[TBL] [Abstract][Full Text] [Related]
24. [Change patterns in the use of antibiotics in hospitals: basis and new perspectives].
Parra A; Gómez J
Med Clin (Barc); 1994 Jan; 102(1):25-9. PubMed ID: 8133682
[No Abstract] [Full Text] [Related]
25. [The diagnostic basis for a rational antibacterial therapy].
Lystad A
Tidsskr Nor Laegeforen; 1968 Feb; 88(4):277-81. PubMed ID: 4876489
[No Abstract] [Full Text] [Related]
26. Therapeutic challenges in the era of antibiotic resistance.
Lee C
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
[TBL] [Abstract][Full Text] [Related]
27. [Infectious diseases are tenacious].
Trabacchi G; Burrus O
Rev Infirm; 1997 Sep; (30):18-24. PubMed ID: 9386552
[No Abstract] [Full Text] [Related]
28. [Changes in the epidemiology of infectious disease in Chile: 1990-2000].
Cabello FC; Claude M
Rev Med Chil; 2002 Oct; 130(10):1185-7; authors reply 1188-9. PubMed ID: 12491840
[No Abstract] [Full Text] [Related]
29. [Microbiology of emerging infectious diseases].
Drancourt M
Rev Prat; 1999 Mar; 49(6):577-9. PubMed ID: 10218388
[No Abstract] [Full Text] [Related]
30. [The worldwide challenges of "new" or reemerging communicable diseases at the dawn of the 21st century].
Werner GH
Ann Pharm Fr; 2001 May; 59(3):147-75. PubMed ID: 11427818
[TBL] [Abstract][Full Text] [Related]
31. [What to think about bacterial resistances in acne?].
Richet H; Andre-Richet B; Gallou FL
Ann Dermatol Venereol; 2001 Apr; 128 Supp 1():S15-7; discussion S31-2. PubMed ID: 11450395
[No Abstract] [Full Text] [Related]
32. Controlling antimicrobial resistance. An integrated action plan for Canadians.
Health Canada and The Canadian Infectious Disease Society
Can Commun Dis Rep; 1997 Nov; 23 Suppl 7():i-iv, 1-32, i-iv, 1-32. PubMed ID: 11195276
[No Abstract] [Full Text] [Related]
33. [Infectious diseases in children--dreams came true, however].
Ashkenazi S
Harefuah; 2012 Aug; 151(8):488-90. PubMed ID: 23350297
[No Abstract] [Full Text] [Related]
34. An infectious disease update on antibiotics: emerging resistance.
Steinberg JS; Kim PJ; Abbruzzese MR
Clin Podiatr Med Surg; 2007 Apr; 24(2):285-309. PubMed ID: 17430771
[TBL] [Abstract][Full Text] [Related]
35. Emerging concepts of biofilms in infectious diseases.
Hung CS; Henderson JP
Mo Med; 2009; 106(4):292-6. PubMed ID: 19753923
[TBL] [Abstract][Full Text] [Related]
36. Fortresses against infection: time for new defences?
Stanwell-Smith R
Perspect Public Health; 2015 Nov; 135(6):266-7. PubMed ID: 26543135
[No Abstract] [Full Text] [Related]
37. Treatment of bacteriuria without urinary signs, symptoms, or systemic infectious illness (S/S/S).
Drinka P
J Am Med Dir Assoc; 2009 Oct; 10(8):516-9. PubMed ID: 19808150
[No Abstract] [Full Text] [Related]
38. Why did it take the Infectious Diseases Society of America so long to address the problem of antibiotic resistance?
Kunin CM
Clin Infect Dis; 2008 Jun; 46(11):1791-2; author reply 1792-3; discussion 1793-4. PubMed ID: 18462117
[No Abstract] [Full Text] [Related]
39. Emerging and re-emerging infectious diseases: a biological evolutionary drama.
Slavkin HC
J Am Dent Assoc; 1997 Jan; 128(1):108-13. PubMed ID: 9002409
[No Abstract] [Full Text] [Related]
40. Coevolution: mankind and microbes.
Mitscher LA
J Nat Prod; 2008 Mar; 71(3):497-509. PubMed ID: 18298076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
